Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Schipper

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab RadioimmunotherapyYuni K Dewaraja, Matthew J Schipper, Jincheng Shen, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's diseaseLaura A Dawson, Naoyuki G Saito, Voravit Ratanatharathorn, et al.
EJNMMI Physics|December 1, 2018
Impact of <sup>90</sup>Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolizationJustin K Mikell, Ravi K Kaza, Peter L Roberson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2005
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancerMary Feng, Siavash Jabbari, Alexander Lin, et al.
Medical Physics|August 22, 2022
Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimizationDaniel F Polan, Marina A Epelman, Victor W Wu, et al.
Translational Oncology|January 5, 2021
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapyMatthew M Cousins, Emily Morris, Christopher Maurino, et al.
American Journal of Clinical Oncology|July 14, 2015
Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field RadiotherapyJessica Zhou, Charles X Fang, Jincheng Shen, et al.
Head & Neck|September 3, 2013
Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapyCandan Demiroz, Jeffrey M Vainshtein, Georgios V Koukourakis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2005
Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancerAlexander Lin, Siavash Jabbari, Francis P Worden, et al.
International Journal of Radiation Oncology, Biology, Physics|August 16, 2018
Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional DamageDaniel Rocky Owen, Phillip S Boonstra, Benjamin L Viglianti, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab RadioimmunotherapyYuni K Dewaraja, Matthew J Schipper, Jincheng Shen, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's diseaseLaura A Dawson, Naoyuki G Saito, Voravit Ratanatharathorn, et al.
EJNMMI Physics|December 1, 2018
Impact of <sup>90</sup>Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolizationJustin K Mikell, Ravi K Kaza, Peter L Roberson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2005
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancerMary Feng, Siavash Jabbari, Alexander Lin, et al.
Medical Physics|August 22, 2022
Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimizationDaniel F Polan, Marina A Epelman, Victor W Wu, et al.
Translational Oncology|January 5, 2021
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapyMatthew M Cousins, Emily Morris, Christopher Maurino, et al.
American Journal of Clinical Oncology|July 14, 2015
Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field RadiotherapyJessica Zhou, Charles X Fang, Jincheng Shen, et al.
Head & Neck|September 3, 2013
Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapyCandan Demiroz, Jeffrey M Vainshtein, Georgios V Koukourakis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2005
Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancerAlexander Lin, Siavash Jabbari, Francis P Worden, et al.
International Journal of Radiation Oncology, Biology, Physics|August 16, 2018
Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional DamageDaniel Rocky Owen, Phillip S Boonstra, Benjamin L Viglianti, et al.
Pageof 13